The effects of AMPA receptor antagonists on kindled seizures and on reflex epilepsy in rodents and primates.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Epilepsy research. Supplement

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 1337444
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heteromeric NMDA Receptors: Molecular and Functional Distinction of Subtypes

  1992cited by this paper
• Long-term potentiation of NMDA receptor-mediated synaptic transmission in the hippocampus

  1991cited by this paper
• The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice.

  1991cited by this paper
• The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy.

  1991cited by this paper
• Activation of the NMDA receptor: a correlate in the dentate gyrus field potential and its relationship to long-term potentiation and kindling.

  1991cited by this paper
• Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not AMPA

  1991cited by this paper
• Cloning of a putative high-affinity kainate receptor expressed predominantly in hippocampal CA3 cells

  1991cited by this paper
• Molecular cloning and characterization of the rat NMDA receptor

  1991cited by this paper
• Molecular cloning and functional expression of glutamate receptor subunit genes.

  1990cited by this paper
• 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia.

  1990cited by this paper
• Pharmacological evidence indicating a role of GABAergic systems in termination of limbic seizures.

  1990cited by this paper
• The NMDA antagonist, MK-801, suppresses long-term potentiation, kindling, and kindling-induced potentiation in the perforant path of the unanesthetized rat.

  1990cited by this paper
• A family of AMPA-selective glutamate receptors.

  1990cited by this paper
• The N-methyl-D-aspartate antagonists aminophosphonovalerate and carboxypiperazinephosphonate retard the development and expression of kindled seizures.

  1990cited by this paper
• Effects of amygdaloid kindling on NMDA receptor function and regulation.

  1989cited by this paper
• Cloning by functional expression of a member of the glutamate receptor family

  1989cited by this paper
• The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures.

  1988cited by this paper
• Inhibition of the development of electrical kindling of the prepyriform cortex by daily focal injections of excitatory amino acid antagonists.

  1988cited by this paper
• NMDA receptors of dentate gyrus granule cells participate in synaptic transmission following kindling

  1987cited by this paper
• MK-801 blocks NMDA receptor-mediated synaptic transmission and long term potentiation in rat hippocampal slices.

  1987cited by this paper
• Anticonvulsant action of amino acid antagonists against kindled hippocampal seizures.

  1984cited by this paper
• Modification of seizure activity by electrical stimulation. II. Motor seizure.

  1972cited by this paper

• Genetically epilepsy-prone rats (GEPRs) and DBA/2 mice: Two animal models of audiogenic reflex epilepsy for the evaluation of new generation AEDs.

  2017cites this paper
• Through the Kindled Dentate Gyrus Enhanced Propagation of Epileptiform Activity

  2015cites this paper
• Targeting α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsy

  2014cites this paper
• Pharmacological preconditioning with GYKI-52466: a prophylactic approach to neuroprotection against ischaemic stroke in the rat

  2013cites this paper
• New AMPA antagonists in epilepsy

  2012cites this paper
• Molecular targets for antiepileptic drug development

  2011cites this paper
• Efficacy of Diet Therapies in the Treatment of Neurological and Neurodegenerative Diseases

  2010cites this paper
• The Aspects and Mechanisms of Cognitive Alterations in Epilepsy: The Role of Antiepileptic Medications

  2009cites this paper
• Visual pattern adaptation in subjects with photoparoxysmal EEG response: evidence for increased visual cortical excitability.

  2009cites this paper
• Neuronal plasticity: implications in epilepsy progression and management

  2007cites this paper
• Metabotropic glutamate receptors as a strategic target for the treatment of epilepsy.

  2006cites this paper
• Diacylglycerol Kinase Epsilon Modulates Rapid Kindling Epileptogenesis

  2006cites this paper
• AMPA receptor antagonists as potential anticonvulsant drugs.

  2005cites this paper
• The preferential mGlu2/3 receptor antagonist, LY341495, reduces the frequency of spike-wave discharges in the WAG/Rij rat model of absence epilepsy.

  2005cites this paper
• Suppression of fully kindled seizure and retardation of kindling acquisition by YM928 in the rat kindling model of epilepsy.

  2004cites this paper
• Glutamate metabotropic receptors as targets for drug therapy in epilepsy.

  2003cites this paper
• Interaction of GYKI 52466, a selective non-competitive antagonist of AMPA/kainate receptors, with conventional antiepileptic drugs in amygdala-kindled seizures in rats.

  2001cites this paper
• Anticonvulsant activity of 3,4-dicarboxyphenylglycines in DBA/2 mice.

  2001cites this paper
• Low doses of AMPA exert anticonvulsant effects on pentylenetetrazol-kindled seizures.

  2001cites this paper
• Anticonvulsive effect of AMPA receptor antagonist GYKI 52466 on 4-aminopyridine-induced cortical ictal activity in rat.

  2000cites this paper
• Cellular Actions of Topiramate: Blockade of Kainate‐Evoked Inward Currents in Cultured Hippocampal Neurons

  2000cites this paper
• Effect of a glutamate receptor antagonist (GYKI 52466) on 4-aminopyridine-induced seizure activity developed in rat cortical slices.

  1999cites this paper
• The in vivo proconvulsant effects of corticotropin releasing hormone in the developing rat are independent of ionotropic glutamate receptor activation.

  1998cites this paper
• Glutamate receptor subunits GluR1 and GluR2/3 distribution shows reorganization in the human epileptogenic hippocampus

  1998cites this paper
• the Kindled Dentate Gyrus Enhanced Propagation of Epileptiform Activity Through

  1998cites this paper
• Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy.

  1998cites this paper
• 2,3-Benzodiazepine AMPA Antagonists

  1998cites this paper
• Enhanced propagation of epileptiform activity through the kindled dentate gyrus.

  1998cites this paper
• A Crucial Role of the α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Subtype of Glutamate Receptors in Piriform and Perirhinal Cortex for the Initiation and Propagation of Limbic Motor Seizures

  1997cites this paper
• A crucial role of the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid subtype of glutamate receptors in piriform and perirhinal cortex for the initiation and propagation of limbic motor seizures.

  1997cites this paper
• Non-NMDA receptor antagonist GYKI 52466 suppresses cortical afterdischarges in immature rats.

  1997cites this paper
• Anticonvulsant action of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline in immature rats: comparison with the effects on motor performance.

  1997cites this paper
• Therapeutic Potential of AMPA Receptor Ligands in Neurological Disorders

  1996cites this paper
• Influence of combined treatment with NMDA and non-NMDA receptor antagonists on electroconvulsions in mice.

  1995cites this paper
• The non-competitive AMPA/kainate receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepileptics.

  1995cites this paper
• Excitatory Amino Acids and Seizures

  1995cites this paper
• The effect of the non-NMDA receptor antagonist GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures.

  1994cites this paper
• Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation?

  1994cites this paper
• The role of glutamate in epilepsy and other CNS disorders

  1994cites this paper
• Low Doses of NMDA Receptor Antagonists Synergistically Increase the Anticonvulsant Effect of the AMPA Receptor Antagonist NBQX in the Kindling Model of Epilepsy

  1993cites this paper
• The Molecular Basis of Kindling

  1993cites this paper